P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Abstract The transcription factor, p53, is critical for many important cellular functions involved in genome integrity, including cell cycle control, DNA damage response, and apoptosis. Disruption of p53 results in a wide range of disorders including cancer, metabolic diseases, and neurodegenerative...

Full description

Bibliographic Details
Main Authors: Kathleen M. Farmer, Gaurav Ghag, Nicha Puangmalai, Mauro Montalbano, Nemil Bhatt, Rakez Kayed
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Acta Neuropathologica Communications
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40478-020-01012-6
_version_ 1828341677316636672
author Kathleen M. Farmer
Gaurav Ghag
Nicha Puangmalai
Mauro Montalbano
Nemil Bhatt
Rakez Kayed
author_facet Kathleen M. Farmer
Gaurav Ghag
Nicha Puangmalai
Mauro Montalbano
Nemil Bhatt
Rakez Kayed
author_sort Kathleen M. Farmer
collection DOAJ
description Abstract The transcription factor, p53, is critical for many important cellular functions involved in genome integrity, including cell cycle control, DNA damage response, and apoptosis. Disruption of p53 results in a wide range of disorders including cancer, metabolic diseases, and neurodegenerative diseases. Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by protein aggregates that contribute to disease pathology. Although p53 is known to aggregate, its propensity to aggregate in AD has never been assessed. Moreover, AD neuropathology includes lethal cell cycle re-entry, excessive DNA damage, and abnormal cell death which are all controlled by p53. Here, we show p53 forms oligomers and fibrils in human AD brain, but not control brain. p53 oligomers can also be detected in htau and P301L mouse models. Additionally, we demonstrate that p53 interacts with tau, specifically tau oligomers, in AD brain and can be recapitulated by in vitro exogenous tau oligomer treatment in C57BL/6 primary neurons. p53 oligomers also colocalize, potentially seeding, endogenous p53 in primary neurons. Lastly, we demonstrate that in the presence of DNA damage, phosphorylated p53 is mislocalized outside the nucleus and p53-mediated DNA damage responders are significantly decreased in AD brain. Control brain shows a healthy DNA damage response, indicating a loss of nuclear p53 function in AD may be due to p53 aggregation and/or interactions with tau oligomers. Given the critical role of p53 in cellular physiology, the disruption of this crucial transcription factor may set an irreversible course towards neurodegeneration in AD and potentially other tauopathies, warranting further investigation.
first_indexed 2024-04-13T23:17:37Z
format Article
id doaj.art-89d5269d42b94a85852128d51a041c5f
institution Directory Open Access Journal
issn 2051-5960
language English
last_indexed 2024-04-13T23:17:37Z
publishDate 2020-08-01
publisher BMC
record_format Article
series Acta Neuropathologica Communications
spelling doaj.art-89d5269d42b94a85852128d51a041c5f2022-12-22T02:25:21ZengBMCActa Neuropathologica Communications2051-59602020-08-018112110.1186/s40478-020-01012-6P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s diseaseKathleen M. Farmer0Gaurav Ghag1Nicha Puangmalai2Mauro Montalbano3Nemil Bhatt4Rakez Kayed5Mitchell Center for Neurodegenerative Diseases, University of Texas Medical BranchMitchell Center for Neurodegenerative Diseases, University of Texas Medical BranchMitchell Center for Neurodegenerative Diseases, University of Texas Medical BranchMitchell Center for Neurodegenerative Diseases, University of Texas Medical BranchMitchell Center for Neurodegenerative Diseases, University of Texas Medical BranchMitchell Center for Neurodegenerative Diseases, University of Texas Medical BranchAbstract The transcription factor, p53, is critical for many important cellular functions involved in genome integrity, including cell cycle control, DNA damage response, and apoptosis. Disruption of p53 results in a wide range of disorders including cancer, metabolic diseases, and neurodegenerative diseases. Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by protein aggregates that contribute to disease pathology. Although p53 is known to aggregate, its propensity to aggregate in AD has never been assessed. Moreover, AD neuropathology includes lethal cell cycle re-entry, excessive DNA damage, and abnormal cell death which are all controlled by p53. Here, we show p53 forms oligomers and fibrils in human AD brain, but not control brain. p53 oligomers can also be detected in htau and P301L mouse models. Additionally, we demonstrate that p53 interacts with tau, specifically tau oligomers, in AD brain and can be recapitulated by in vitro exogenous tau oligomer treatment in C57BL/6 primary neurons. p53 oligomers also colocalize, potentially seeding, endogenous p53 in primary neurons. Lastly, we demonstrate that in the presence of DNA damage, phosphorylated p53 is mislocalized outside the nucleus and p53-mediated DNA damage responders are significantly decreased in AD brain. Control brain shows a healthy DNA damage response, indicating a loss of nuclear p53 function in AD may be due to p53 aggregation and/or interactions with tau oligomers. Given the critical role of p53 in cellular physiology, the disruption of this crucial transcription factor may set an irreversible course towards neurodegeneration in AD and potentially other tauopathies, warranting further investigation.http://link.springer.com/article/10.1186/s40478-020-01012-6p53TauOligomersDNA damageSeedingCross-seeding
spellingShingle Kathleen M. Farmer
Gaurav Ghag
Nicha Puangmalai
Mauro Montalbano
Nemil Bhatt
Rakez Kayed
P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease
Acta Neuropathologica Communications
p53
Tau
Oligomers
DNA damage
Seeding
Cross-seeding
title P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease
title_full P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease
title_fullStr P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease
title_full_unstemmed P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease
title_short P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease
title_sort p53 aggregation interactions with tau and impaired dna damage response in alzheimer s disease
topic p53
Tau
Oligomers
DNA damage
Seeding
Cross-seeding
url http://link.springer.com/article/10.1186/s40478-020-01012-6
work_keys_str_mv AT kathleenmfarmer p53aggregationinteractionswithtauandimpaireddnadamageresponseinalzheimersdisease
AT gauravghag p53aggregationinteractionswithtauandimpaireddnadamageresponseinalzheimersdisease
AT nichapuangmalai p53aggregationinteractionswithtauandimpaireddnadamageresponseinalzheimersdisease
AT mauromontalbano p53aggregationinteractionswithtauandimpaireddnadamageresponseinalzheimersdisease
AT nemilbhatt p53aggregationinteractionswithtauandimpaireddnadamageresponseinalzheimersdisease
AT rakezkayed p53aggregationinteractionswithtauandimpaireddnadamageresponseinalzheimersdisease